The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease

doi:10.1007/s12072-020-10094-2

科研成果详情

题名	The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
作者	Eslam, Mohammed 1; Sarin, Shiv K.2; Wong, Vincent Wai-Sun 3; Fan, Jian-Gao 4; Kawaguchi, Takumi 5; Ahn, Sang Hoon 6; Zheng, Ming-Hua7,8; Shiha, Gamal 9,10; Yilmaz, Yusuf 11,12; Gani, Rino 13; Alam, Shahinul 14; Dan, Yock Young 15; Kao, Jia-Horng 16,17,18,19; Hamid, Saeed 20; Cua, Ian Homer 21; Chan, Wah-Kheong 22; Payawal, Diana 23; Tan, Soek-Siam 24; Tanwandee, Tawesak 25; Adams, Leon A.26; Kumar, Manoj 2; Omata, Masao 27,28; George, Jacob 1
发表日期	2020-12
发表期刊	HEPATOLOGY INTERNATIONAL 影响因子和分区
语种	英语
原始文献类型	Article
其他关键词	HEPATITIS-B-VIRUS ; LONG-TERM OUTCOMES ; QUALITY-OF-LIFE ; HEPATOCELLULAR-CARCINOMA PATIENTS ; MAGNETIC-RESONANCE ELASTOGRAPHY ; PLACEBO-CONTROLLED TRIAL ; SIMPLE NONINVASIVE INDEX ; CORONARY-ARTERY-DISEASE ; VISCERAL ADIPOSE-TISSUE ; BODY-MASS INDEX
摘要	Metabolic associated fatty liver disease (MAFLD) is the principal worldwide cause of liver disease and affects nearly a quarter of the global population. The objective of this work was to present the clinical practice guidelines of the Asian Pacific Association for the Study of the Liver (APASL) on MAFLD. The guidelines cover various aspects of MAFLD including its epidemiology, diagnosis, screening, assessment, and treatment. The document is intended for practical use and for setting the stage for advancing clinical practice, knowledge, and research of MAFLD in adults, with specific reference to special groups as necessary. The guidelines also seek to improve patient care and awareness of the disease and assist stakeholders in the decision-making process by providing evidence-based data. The guidelines take into consideration the burden of clinical management for the healthcare sector.
出版者	SPRINGER
出版地	NEW YORK
ISSN	1936-0533
EISSN	1936-0541
卷号	14 期号:6 页码:889-919
DOI	10.1007/s12072-020-10094-2
页数	31
WOS类目	Gastroenterology & Hepatology
WOS研究方向	Gastroenterology & Hepatology
WOS记录号	WOS:000574340000001
收录类别	SCIE ; PUBMED
URL	查看原文
PubMed ID	33006093
ESI高被引论文	2021-05 ; 2021-07 ; 2021-11 ; 2022-01 ; 2022-03 ; 2022-07 ; 2022-09 ; 2022-11 ; 2023-01 ; 2023-03 ; 2023-05 ; 2023-07 ; 2023-09 ; 2023-11 ; 2024-01 ; 2024-03 ; 2024-05 ; 2024-07 ; 2024-09 ; 2024-11
通讯作者地址	[Eslam, Mohammed;George, Jacob]Westmead Hosp, Storr Liver Ctr, Westmead Inst Med Res, Westmead, NSW 2145, Australia. ; [Sarin, Shiv K.]Inst Liver & Biliary Sci, Dept Hepatol, New Delhi, India.
引用统计	被引频次：209[WOS] [WOS记录] [WOS相关记录]
文献类型	期刊论文
条目标识符	https://kms.wmu.edu.cn/handle/3ETUA0LF/20841
专题	附属第一医院
通讯作者	Eslam, Mohammed; Sarin, Shiv K.; George, Jacob
作者单位	1.Westmead Hosp, Storr Liver Ctr, Westmead Inst Med Res, Westmead, NSW 2145, Australia; 2.Inst Liver & Biliary Sci, Dept Hepatol, New Delhi, India; 3.Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China; 4.Shanghai Jiao Tong Univ, Ctr Fatty Liver, Dept Gastroenterol, Xin Hua Hosp,Sch Med,Shanghai Key Lab Pediat Gast, Shanghai, Peoples R China; 5.Kurume Univ, Div Gastroenterol, Sch Med, Kurume, Fukuoka, Japan; 6.Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea; 7.Wenzhou Med Univ, Affiliated Hosp 1, Dept Hepatol, MAFLD Res Ctr, Wenzhou, Peoples R China; 8.Wenzhou Med Univ, Inst Hepatol, Wenzhou, Peoples R China; 9.Mansoura Univ, Dept Internal Med, Hepatol & Gastroenterol Unit, Fac Med, Mansoura, Egypt; 10.Egyptian Liver Res Inst & Hosp ELRIAH, Sherbin, El Mansoura, Egypt; 11.Marmara Univ, Sch Med, Dept Gastroenterol, Istanbul, Turkey; 12.Marmara Univ, Inst Gastroenterol, Istanbul, Turkey; 13.Univ Indonesia, Dept Internal Med, Hepatobiliary Div, Dr Cipto Mangunkusumo Natl Gen Hosp, Pangeran Diponegoro Rd 71st, Cent Jakarta 10430, Indonesia; 14.Bangabandhu Sheikh Mujib Med Univ, Dept Hepatol, Dhaka, Bangladesh; 15.Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore; 16.Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, 1 Chang Te St, Taipei 10002, Taiwan; 17.Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; 18.Natl Taiwan Univ, Natl Taiwan Univ Hosp, Hepatitis Res Ctr, Taipei, Taiwan; 19.Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan; 20.Aga Khan Univ, Dept Med, Karachi, Pakistan; 21.St Lukes Med Ctr, Inst Digest & Liver Dis, Global City, Philippines; 22.Univ Malaya, Dept Med, Gastroenterol & Hepatol Unit, Fac Med, Kuala Lumpur, Malaysia; 23.Cardinal Santos Med Ctr, Dept Med, Mandaluyong, Philippines; 24.Selayang Hosp, Dept Hepatol, Batu Caves, Malaysia; 25.Mahidol Univ, Fac Med, Dept Med, Siriraj Hosp, Bangkok, Thailand; 26.Univ Western Australia, Sch Med, Fac Med & Hlth Sci, Nedlands, WA, Australia; 27.Yamanashi Cent Hosp, Dept Gastroenterol, Yamanashi, Japan; 28.Univ Tokyo, Tokyo, Japan
推荐引用方式 GB/T 7714	Eslam, Mohammed,Sarin, Shiv K.,Wong, Vincent Wai-Sun,et al. The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease[J]. HEPATOLOGY INTERNATIONAL,2020,14(6):889-919.
APA	Eslam, Mohammed., Sarin, Shiv K.., Wong, Vincent Wai-Sun., Fan, Jian-Gao., Kawaguchi, Takumi., ... & George, Jacob. (2020). The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. HEPATOLOGY INTERNATIONAL, 14(6), 889-919.
MLA	Eslam, Mohammed,et al."The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease".HEPATOLOGY INTERNATIONAL 14.6(2020):889-919.